Medtronic Inc

Summary

Organization: Medtronic Inc
Country: USA

Top Publications

  1. ncbi Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database
    John B Welsh
    Medtronic, Inc, 18000 Devonshire Street, Northridge, CA 91325, USA
    Pediatr Endocrinol Rev 7:413-6. 2010
  2. pmc Diabetes care - insulin delivery in a changing world
    Alan Marcus
    Medtronic Diabetes, Northridge, California, USA
    Medscape J Med 10:120. 2008
  3. ncbi [Discrete-event simulation models in the economic evaluation of health technologies and health products]
    José Manuel Rodríguez Barrios
    Departamento de Economía de la Salud y Reembolso, Medtronic Ibérica S A, Madrid, Spain
    Gac Sanit 22:151-61. 2008
  4. doi Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias
    Yong Fu Xiao
    Cardiac Rhythm Disease Management, Medtronic Inc, 8200 Coral Sea Street NE, Mounds View, MN 55112, USA
    Am J Physiol Heart Circ Physiol 294:H2212-8. 2008
  5. doi Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model
    John M Zanella
    Medtronic, Spinal and Biologics, Memphis, TN 38132, USA
    Spine (Phila Pa 1976) 33:227-34. 2008
  6. ncbi Moving on...or moving out? How you can develop a physician leadership retention and transition plan
    Dennis Wipperling
    PRACTICE Advantage, Minneapolis, USA
    MGMA Connex 7:34-7, 1. 2007
  7. pmc Noninvasive electrocardiographic imaging of arrhythmogenesis: insights from modeling and human studies
    Raja N Ghanem
    Medtronic Cardiac Rhythm Disease Management, Minneapolis, MN, USA
    J Electrocardiol 40:S169-73. 2007
  8. ncbi Prediction of vasovagal syncope from heart rate and blood pressure trend and variability: experience in 1,155 patients
    Nathalie Virag
    Medtronic Europe, Tolochenaz, Switzerland
    Heart Rhythm 4:1375-82. 2007
  9. ncbi Comparison of Laplacian and bipolar ECGs for R-wave detection during noise
    Raja N Ghanem
    Cardiac Rhythm Disease Manage, Medtronic Inc, Minneapolis, MN 55432, USA
    Conf Proc IEEE Eng Med Biol Soc 1:3994-7. 2006
  10. ncbi Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent
    Kishore Udipi
    Medtronic CardioVascular, 3576 Unocal Pl, Santa Rosa, California 95403, USA
    J Biomed Mater Res A 85:1064-71. 2008

Detail Information

Publications62

  1. ncbi Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database
    John B Welsh
    Medtronic, Inc, 18000 Devonshire Street, Northridge, CA 91325, USA
    Pediatr Endocrinol Rev 7:413-6. 2010
    ..This study examined CGM usage and its relationship to insulin delivery and glycemia in CareLink users with type 1 diabetes mellitus (T1DM)...
  2. pmc Diabetes care - insulin delivery in a changing world
    Alan Marcus
    Medtronic Diabetes, Northridge, California, USA
    Medscape J Med 10:120. 2008
    ..In addition, exciting developments in technology for self-monitoring of blood glucose have increased the potential for optimal glycemic control. This review discusses how these approaches can help patients manage their diabetes...
  3. ncbi [Discrete-event simulation models in the economic evaluation of health technologies and health products]
    José Manuel Rodríguez Barrios
    Departamento de Economía de la Salud y Reembolso, Medtronic Ibérica S A, Madrid, Spain
    Gac Sanit 22:151-61. 2008
    ....
  4. doi Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias
    Yong Fu Xiao
    Cardiac Rhythm Disease Management, Medtronic Inc, 8200 Coral Sea Street NE, Mounds View, MN 55112, USA
    Am J Physiol Heart Circ Physiol 294:H2212-8. 2008
    ..Pericardial administration of n-3 PUFAs could represent a novel approach to treating or preventing myocardial infarctions...
  5. doi Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model
    John M Zanella
    Medtronic, Spinal and Biologics, Memphis, TN 38132, USA
    Spine (Phila Pa 1976) 33:227-34. 2008
    ..The effects of a low, local dose of a tumor necrosis factor-alpha (TNF-alpha) inhibitor on neuropathic pain behaviors in a rat chronic constriction injury model were evaluated...
  6. ncbi Moving on...or moving out? How you can develop a physician leadership retention and transition plan
    Dennis Wipperling
    PRACTICE Advantage, Minneapolis, USA
    MGMA Connex 7:34-7, 1. 2007
    ..Your practice should seek to retain physician leaders for the sake of the owners/shareholders, the physicians, the medical group and the community...
  7. pmc Noninvasive electrocardiographic imaging of arrhythmogenesis: insights from modeling and human studies
    Raja N Ghanem
    Medtronic Cardiac Rhythm Disease Management, Minneapolis, MN, USA
    J Electrocardiol 40:S169-73. 2007
    ....
  8. ncbi Prediction of vasovagal syncope from heart rate and blood pressure trend and variability: experience in 1,155 patients
    Nathalie Virag
    Medtronic Europe, Tolochenaz, Switzerland
    Heart Rhythm 4:1375-82. 2007
    ..Vasovagal syncope (VVS) is a complex fainting disorder commonly triggered by orthostatic stress...
  9. ncbi Comparison of Laplacian and bipolar ECGs for R-wave detection during noise
    Raja N Ghanem
    Cardiac Rhythm Disease Manage, Medtronic Inc, Minneapolis, MN 55432, USA
    Conf Proc IEEE Eng Med Biol Soc 1:3994-7. 2006
    ..Sensing performance showed that bipolar ECGs resulted in marginally superior sensing accuracy compared to Laplacian ECGs. In conclusion, Laplacian ECGs offer no advantage in SNR compared with standard bipolar ECGs...
  10. ncbi Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent
    Kishore Udipi
    Medtronic CardioVascular, 3576 Unocal Pl, Santa Rosa, California 95403, USA
    J Biomed Mater Res A 85:1064-71. 2008
    ..The polymer blend system is also well tolerated by the hydrophilic environment in vivo, as demonstrated through porcine studies...
  11. ncbi Development of doxycycline-eluting delivery systems based on SynBiosys biodegradable multi-block copolymers
    M Gillissen
    Medtronic Bakken Research Center, S and T Biomaterials Technology, Maastricht, The Netherlands
    J Control Release 116:e90-2. 2006
  12. ncbi Determining the number of clusters using the weighted gap statistic
    Mingjin Yan
    Medtronic Sofamor Danek, 1800 Pyramid Place, Memphis, Tennessee 38132, USA
    Biometrics 63:1031-7. 2007
    ..Simulation studies and real data are investigated and compared among these proposed methods as well as with the original gap method...
  13. ncbi Direct measurements of membrane time constant during defibrillation strength shocks
    Vinod Sharma
    Medtronic Inc, Minneapolis, Minnesota 55432, USA
    Heart Rhythm 4:478-86. 2007
    ..The time constant of membrane polarization (tau(m)) is a key variable for such modeling efforts...
  14. ncbi Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks
    Bruce D Gunderson
    Medtronic, Inc, Minneapolis, Minnesota 55432, USA
    Pacing Clin Electrophysiol 30:157-65. 2007
    ..Our goal was to estimate the effect of the programmed number of intervals to detect (NID) ventricular fibrillation (VF) on ICD temporal episode rate, unnecessary shocks, and delay in detection of VF...
  15. doi Deep brain stimulation devices: a brief technical history and review
    Robert J Coffey
    Medtronic, Inc, 7000 Central Avenue NE, Minneapolis, MN 55432, USA
    Artif Organs 33:208-20. 2009
    ..We will briefly review the history and present status of DBS from a technical and device-oriented perspective, with an eye toward future advances...
  16. doi Experience with Medicare's new technology add-on payment program
    Alexandra T Clyde
    Medtronic Inc, Minneapolis, Minnesota, USA
    Health Aff (Millwood) 27:1632-41. 2008
    ....
  17. doi Changes in right ventricular pressures between hemodialysis sessions recorded by an implantable hemodynamic monitor
    Barbro Kjellstrom
    Medtronic, Inc, Minneapolis, Minnesota, USA
    Am J Cardiol 103:119-23. 2009
    ..The results also suggest that more frequent dialysis may avoid excessive pressure increase, but this needs to be investigated further in future studies...
  18. doi Medical practice perspective: identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain
    Robert J Coffey
    Medtronic Inc, Minneapolis, Minnesota 55432, USA
    Pain Med 11:1001-9. 2010
    ..Both of those objectives involve judgments, which may be controversial and are subject to practical limitations...
  19. doi A theoretical and experimental analysis of radiofrequency ablation with a multielectrode, phased, duty-cycled system
    Michael Lau
    Medtronic Ablation Frontiers, Carlsbad, CA, USA
    Pacing Clin Electrophysiol 33:1089-100. 2010
    ..Computational analysis of a finite element model of a three-dimensional, multielectrode, cardiac ablation catheter, powered by a temperature-controlled, multiphase, duty-cycled RF generator, is presented...
  20. ncbi Hysteresis in human HCN4 channels: a crucial feature potentially affecting sinoatrial node pacemaking
    Yong Fu Xiao
    Cardiac Rhythm Disease Management, Medtronic Inc, Mounds View, MN 55112, USA
    Sheng Li Xue Bao 62:1-13. 2010
    ..Therefore, hHCN4 hysteresis potentially plays a crucial role in human SAN pacemaking activity...
  21. doi Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events
    Paul D Ziegler
    Medtronic Inc, Minneapolis, Minn, USA
    Stroke 41:256-60. 2010
    ..We studied patients with previous thromboembolic events (TE) who were implanted with devices capable of continuous arrhythmia monitoring to comprehensively quantify the incidence and duration of newly detected AT/AF...
  22. doi Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat noncancer pain
    Robert J Coffey
    Divisions of Neuromodulation Clinical Research, Regulatory Vigilance, and Biostatistics, Medtronic Inc, 7000 Central Avenue NE, Minneapolis, MN 55432, USA
    Anesthesiology 111:881-91. 2009
    ..The authors performed investigations to quantify that mortality and compare the results to control populations, including spinal cord stimulation and low back surgery...
  23. doi Spinal cord stimulation for complex regional pain syndrome
    Maneesh Shrivastav
    Medtronic Neuromodulation, 7000 Central Ave NE, Minneapolis, Minnesota, 55432 USA
    Conf Proc IEEE Eng Med Biol Soc 2009:2033-6. 2009
    ..This review focuses on the effects of SCS on CRPS. In addition, an overview of the state of the art technologies used for implantable SCS medical devices is also provided...
  24. doi Exit vs. entrance block testing for cardiac lesion assessment
    Sarah E Ahlberg
    CardioVascular division of Medtronic, Inc, Fridley, MN 55432, USA
    Conf Proc IEEE Eng Med Biol Soc 2009:3282-5. 2009
    ..However, the most robust lesion assessment will occur when both methods are employed so that the physician has the most information available for analysis...
  25. doi Cardiac ablation via electroporation
    Jinback Hong
    CardioVascular division of Medtronic, Inc, Fridley, MN 55432, USA
    Conf Proc IEEE Eng Med Biol Soc 2009:3381-4. 2009
    ..High transmurality success rates also suggest the possibility of applying this new ablation modality to cardiac ablation. A long term study confirming lesion durability is necessary to warrant the successful adoption of this technique...
  26. doi Insulin for implantable pumps
    William Van Antwerp
    Medtronic Strategy and Innovation, Woodland Hills, CA 91367, USA
    Conf Proc IEEE Eng Med Biol Soc 2009:238-41. 2009
    ..Implantable Devices require biotechnology drugs with a variety of properties. In this paper we discuss some of the more challenging issues with implantable devices...
  27. doi Evidence development and publication planning: strategic process
    Michael R Wittek
    Health Policy and Planning, Medtronic Inc, 7000 Central Ave NE, RCE395, Minneapolis, MN 55432, USA
    Curr Med Res Opin 25:2723-7. 2009
    ..The purpose of this manuscript is to offer a six-step strategic process leading to a portfolio of evidence that meets the informational needs of providers, payers, and governmental agencies concerning patient access to a therapy...
  28. ncbi Novel high-throughput polymer biocompatibility screening designed for SAR (structure-activity relationship): application for evaluating polymer coatings for cardiovascular drug-eluting stents
    Ayala Hezi-Yamit
    Medtronic CardioVascular, Santa Rosa, CA 95403, USA
    Comb Chem High Throughput Screen 12:664-76. 2009
    ..The results of this evaluation reveal a remarkable correlation between polymer hydrophobicity and its ability to provoke inflammatory response...
  29. doi Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: relationship to symptoms and other variables
    Gianluca Quirino
    Ivrea Hospital, Ivrea, Italy
    Pacing Clin Electrophysiol 32:91-8. 2009
    ..The study prospectively evaluated the burden of asymptomatic AF episodes in pacemaker patients (for sick sinus syndrome) with a history of documented paroxysmal AF...
  30. doi Surface slide track mapping of implants for total disc arthroplasty
    Philippe E Paré
    Medtronic, Spinal and Biologics, 1800 Pyramid Place, Memphis, TN 38132, USA
    J Biomech 42:131-9. 2009
    ..Slide tracks were also found to be insensitive to the type of simulator under all testing conditions...
  31. ncbi Metabolic modelling and the closed-loop insulin delivery problem
    Garry Steil
    Medtronic MiniMed, Northridge, CA 91325, USA
    Diabetes Res Clin Pract 74:S183-6. 2006
    ..This approach is contrasted with traditional control systems engineering...
  32. ncbi Cyclic AMP-dependent modulation of cardiac L-type Ca2+ and transient outward K+ channel activities by epoxyeicosatrienoic acids
    Yong Fu Xiao
    Cardiac Rhythm Disease Management, Medtronic Inc, 7000 Central Avenue NE, B252, Minneapolis, MN 55432 3576, and Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA
    Prostaglandins Other Lipid Mediat 82:11-8. 2007
    ..This brief review summarizes EET-induced modulation of cardiac ion channels...
  33. ncbi The acute effects of posterior fusion instrumentation on kinematics and intradiscal pressure of the human lumbar spine
    Fred J Molz
    Spine Biomechanics Laboratory, Birmingham VA Medical Center, Alabama, USA
    J Spinal Disord Tech 16:171-9. 2003
    ..The most significant decreases and increases in IDP occurred at the instrumented level during sagittal and transverse plane testing...
  34. ncbi Hierarchical statistical modelling of influenza epidemic dynamics in space and time
    Andrew S Mugglin
    Arrhythmia Management Clinical and Outcomes Research, Medtronic Inc, 7000 Central Avenue NE, MS CW300, Minneapolis MN 55432 3576, USA
    Stat Med 21:2703-21. 2002
    ..We take a Bayesian approach, using Markov chain Monte Carlo to compute posterior estimates of all parameters of interest. We apply the methodology to an influenza epidemic in Scotland during the years 1989-1990...
  35. ncbi Automatic termination of radiofrequency energy upon catheter dislocation
    O Eick
    Medtronic Bakken Research Center, Maastricht, The Netherlands
    Biomed Tech (Berl) 47:186-90. 2002
    ..We conclude that the developed device may improve safety during ablation procedures of cardiac arrhythmias...
  36. ncbi Atrial pacing lead location alters the effects of atrioventricular delay on atrial and ventricular hemodynamics
    Douglas A Hettrick
    Medtronic, Incorporated, Minneapolis, Minnesota 55432, USA
    Pacing Clin Electrophysiol 25:888-96. 2002
    ..The results indicate that the atrial contribution to cardiac output depends on AV timing and atrial lead location in isoflurane-anesthetized dogs with AV nodal conduction block...
  37. ncbi Intrapericardial therapeutics: a pharmacodynamic and pharmacokinetic comparison between pericardial and intravenous procainamide delivery
    Michael R Ujhelyi
    Medtronic Cardiac Rhythm Management Research, Minneapolis, MN 55432, USA
    J Cardiovasc Electrophysiol 13:605-11. 2002
    ..Procainamide delivery into the pericardial space may produce a greater and more prolonged electrophysiologic effect, particularly in thin superficial atrial tissue, compared with intravenous delivery...
  38. ncbi Calculating pass-through and outlier payments under APCs
    M Gold
    Medtronic, Monsey, New York, USA
    Healthc Financ Manage 55:54-7. 2001
    ..Successfully calculating payments for pass-through and outlier devices requires that financial managers have a thorough knowledge of the medical devices, drugs, and biologicals being used in their outpatient surgery departments...
  39. ncbi Prospective postmarket device studies versus returned product analysis as a predictor of system survival
    T R Pratt
    Department of Tathyarrhythmia Clinical and Outcomes Research, Medtronic, Inc, Minneapolis, Minnesota 55126 2983, USA
    Pacing Clin Electrophysiol 23:1150-5. 2000
    ..The authors conclude that prospective chronic device studies are a superior tool for the ongoing monitoring of implanted device performance compared to RPA-based reports...
  40. ncbi Correlation of esophageal conductance measurements with aortic and left ventricular diameters and stroke volume
    D A Hettrick
    Department of Anesthesiology, Medical College of Wisconsin, Milwaukee 53226, USA
    IEEE Trans Biomed Eng 47:559-64. 2000
    ..Esophageal conductance measurements are directly influenced by local hemodynamic events adjacent to the site of measurement...
  41. ncbi Popping phenomena in temperature-controlled radiofrequency ablation: when and why do they occur?
    O J Eick
    Medtronic Bakken Research Center, Maastricht, The Netherlands
    Pacing Clin Electrophysiol 23:253-8. 2000
    ..Under these conditions the tissue temperature can be much higher than the temperature measured at the tip electrode and can potentially reach 100 degrees C causing intramyocardial steam formation and a popping phenomenon...
  42. ncbi Platelets and whole blood coagulation
    R F Baugh
    Research and Scientific Affairs, Medtronic Perfusion Systems, Parker, Colorado 80134, USA
    Perfusion 15:41-50. 2000
    ....
  43. ncbi Induction of electrical heterogeneity impairs ventricular defibrillation: an effect specific to regional conduction velocity slowing
    M R Ujhelyi
    University of Georgia College of Pharmacy, Augusta VA Medical Center, and Medical College of Georgia School of Medicine, Augusta, USA
    Circulation 100:2534-40. 1999
    ..This study determined whether dispersion of conduction velocity, refractoriness, or excitability increases biphasic shock defibrillation energy requirements (DERs)...
  44. ncbi Action potentials that mimic fibrillation activate sodium current
    M R Ujhelyi
    University of Georgia College of Pharmacy, Augusta, GA, USA
    J Mol Cell Cardiol 31:1673-84. 1999
    ..Therefore, it is likely that the inward sodium channel contributes to wave front propagation during ventricular fibrillation...
  45. ncbi Investigation of the phenomenon of electrostatic compromise of a plastic fiber heat exchanger
    R J Elgas
    Research and Development, Medtronic Cardiac Surgery, Cardiopulmonary Division, Anaheim, California 92807, USA
    Perfusion 14:133-40. 1999
    ..The CEL can be either external or internal to the oxygenator. Each of these solutions was validated and the product has been reintroduced for clinical use...
  46. ncbi Tissue temperature-controlled radiofrequency ablation
    Olaf J Eick
    Medtronic Bakken Research Center, Endepolsdomein 5, 6229 GW Maastricht, The Netherlands
    Pacing Clin Electrophysiol 26:725-30. 2003
    ..Lesion size during tissue temperature-controlled radiofrequency delivery increases with increasing target tissue temperature and becomes independent of flow and electrode to tissue contact...
  47. ncbi Atrial pacing lead location alters the hemodynamic effects of atrial-ventricular delay in dogs with pacing induced cardiomyopathy
    Douglas A Hettrick
    Medtronic, Inc, Minneapolis, Minnesota 55432, USA
    Pacing Clin Electrophysiol 26:853-61. 2003
    ..Atrial lead location affects indices of LV performance independent of AV delay during dual chamber pacing in dogs with cardiomyopathy...
  48. ncbi Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis
    Garry M Steil
    Medtronic MiniMed, Inc, Northridge, California 91325, USA
    Diabetes Technol Ther 5:953-64. 2003
    ..However, the PID model could maintain fasting euglycemia and was more stable under closed-loop conditions, and thus is more suited for such conditions...
  49. ncbi Comparison of continuous versus intermittent monitoring of atrial arrhythmias
    Paul D Ziegler
    Medtronic Inc, Minneapolis, Minnesota
    Heart Rhythm 3:1445-52. 2006
    ..The ability of intermittent or symptom-based monitoring to accurately identify patients with atrial tachycardia/atrial fibrillation (AT/AF) and to quantify AT/AF burden is not well established...
  50. ncbi Minimally invasive approach to the child with palpitations
    Kesava Rajagopalan
    Medtronic of Canada Ltd, Field Clinical Engineer, 305 601 W Broadway, Vancouver, BC, V5Z 4C2, Canada
    Expert Rev Cardiovasc Ther 4:681-93. 2006
    ..The primary focus for the clinician is to determine whether the etiology is benign in nature or whether there is underlying heart disease that may carry a more serious prognosis...
  51. ncbi A method to calculate tissue impedance through a standard bipolar pacing lead
    G C Bini
    UTIC, Ospedali Riuniti di Livorno, Viale Alfieri, 36, Livorno, 57100, Italy
    Cardiovasc Eng 6:43-52. 2006
    ..The measured values of the saline solution impedance were compared to the values calculated through the formula...
  52. pmc Dominant negative retinoic acid receptor initiates tumor formation in mice
    Tara S Kupumbati
    Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
    Mol Cancer 5:12. 2006
    ..This begs the question of whether chronic physiological RAR activation by endogenous retinoids is likewise anti-tumorigenic...
  53. ncbi Exercise in a hot environment: comparison of two different fluid intake patterns
    M A Ferguson
    Clinical and Strategic Development, Medtronic Sofamor Danek, Memphis, TN 38132, USA
    J Sports Med Phys Fitness 45:501-6. 2005
    ..This study attempted to determine if ingesting fluid either in a single bolus or intermittently during exercise had different results in thermoregulatory parameters and thirst in a hot environment...
  54. ncbi Closed-loop insulin delivery - what lies between where we are and where we are going?
    Garry M Steil
    Medtronic MiniMed, Northridge, CA 91325, USA
    Expert Opin Drug Deliv 2:353-62. 2005
    ..Existing strategies for open-loop pump therapy are presented with the objective of defining a path to advance from the existing physician/patient determined insulin therapy to a completely automated system...
  55. ncbi Remote interactions with implantable devices: from device follow-up to chronic patient management
    Kenneth Mark Riff
    Medtronic Inc Arden Hills, MN 55432, USA Hawaii Heart Brain Center at North Hawaii Community Hospital, Kamuela, HI 96743, USA
    J Electrocardiol 38:193. 2005
  56. ncbi Trans-telephonic monitoring of continuous haemodynamic measurements in heart failure patients
    Barbro Kjellstrom
    Heart Failure Research, Medtronic Inc, Minneapolis, Minnesota 55432, USA
    J Telemed Telecare 11:240-4. 2005
    ..It also suggested that transmission success was independent of patient age or gender...
  57. ncbi Development of implantable devices for continuous ambulatory monitoring of central hemodynamic values in heart failure patients
    Tom Bennett
    Heart Failure Research, Medtronic Inc, MS CW320, 7000 Central Avenue NE, Minneapolis, MN 55432, USA
    Pacing Clin Electrophysiol 28:573-84. 2005
    ..A series of patient studies are reported here that were conducted to identify device requirements and verify the feasibility of continuous hemodynamic monitoring in CHF patients and devices for remote transfer and use of these data...
  58. ncbi Modeling insulin action for development of a closed-loop artificial pancreas
    G M Steil
    Medtronic MiniMed, Northridge, California 91325, USA
    Diabetes Technol Ther 7:94-108. 2005
    ..While no consensus model is proposed, relevant issues needing to be addressed are highlighted...
  59. ncbi Marginalized binary mixed-effects models with covariate-dependent random effects and likelihood inference
    Zengri Wang
    Medtronic Inc, Saint Paul, Minnesota 55126, USA
    Biometrics 60:884-91. 2004
    ..We discuss the relation between this approach and some existing models and compare the approaches on two datasets...
  60. ncbi Flow characterization of the ADVANTAGE and St. Jude Medical bileaflet mechanical heart valves
    Mark C S Shu
    Medtronic Heart Valves, Inc, Santa Ana, CA 92705, USA
    J Heart Valve Dis 13:814-22. 2004
    ..The study aim was to characterize time-dependent flow fields and flow structures within the ADVANTAGE (ADV) and St. Jude Medical (SJM) prosthetic bileaflet mechanical heart valves...
  61. pmc Thermodynamic phase plane analysis of ventricular contraction and relaxation
    Mustafa Karamanoglu
    Cardiovascular Biophysics Laboratory, Washington University School of Medicine, Washington University in St Louis, 660 South Euclid Ave, Box 8086, St, Louis, MO 63110, USA
    Biomed Eng Online 3:6. 2004
    ..Additional conceptual difficulty arises when ventricular/vascular coupling is considered using P, V variables...
  62. ncbi Finite element analysis of defibrillation fields in a human torso model for ventricular defibrillation
    X Min
    Medtronic, Minneapolis, MN 55432, USA
    Prog Biophys Mol Biol 69:353-86. 1998
    ..Analysis of the effect of RV, SVC and Can electrode dimensions and locations can have an important impact on defibrillation lead designs...